Component 3: Schizophrenia — Eduqas A-Level Psychology

The Schizophrenia option within Eduqas Component 3 investigates the complex clinical reality of a severe psychiatric disorder affecting approximately 1% of the global population. Students examine issues surrounding diagnosis and classification via DSM-5 and ICD-11, comparing biological explanations including genetics, the dopamine hypothesis, and neural correlates with psychological perspectives such as family dysfunction and cognitive deficits.

This topic connects foundational psychological debates, such as nature versus nurture, reductionism versus holism, and idiographic versus nomothetic approaches, to real-world clinical practice. By contrasting biological interventions like typical and atypical antipsychotics against therapies like CBTp and family therapy, learners develop a critical, evidence-based understanding of psychiatric intervention and modern interactionist frameworks.

• →Classification and Diagnosis: Clinical characteristics, including positive symptoms (hallucinations, delusions) and negative symptoms (avolition, alogia, anhedonia), assessed through reliability (test-retest, inter-rater) and validity (co-morbidity, symptom overlap, gender and cultural bias).
• →Biological Aetiology: Polygenic inheritance (e.g., Ripke et al.), the revised dopamine hypothesis (hyperdopaminergia in subcortical areas vs. hypodopaminergia in cortical areas), and structural neural correlates like enlarged ventricles and reduced grey matter.
• →Psychological Formulations: Family dysfunction theories (Bateson's double-bind, high Expressed Emotion) and Frith's cognitive model of meta-representation and central control dysfunction.
• →Therapeutic Interventions: Typical (chlorpromazine) versus atypical (clozapine) antipsychotic drug therapy; Cognitive Behavioural Therapy for psychosis (CBTp), family therapy, and token economy systems within inpatient care.

• Explains the dopamine hypothesis as the proposal that disturbed dopamine activity in the brain underlies schizophrenic symptoms such as hallucinations.
• Explains enlarged ventricles as a structural brain finding in which fluid-filled spaces are larger, suggesting reduced brain tissue in some people with schizophrenia.
• Explains cannabis influence as the proposal that heavy cannabis use, particularly in adolescence, may disrupt brain chemistry and increase the risk of psychotic symptoms.
• Distinguishes biological explanations that concern neurotransmitters from those that concern brain structure, and states a plausible limitation such as correlation not proving causation.
• Identifies at least two named individual differences explanations from the specified examples
• Explains the proposed mechanism of each chosen explanation rather than only naming it
• Supports each explanation with relevant evidence or clinical description
• Evaluates each explanation by weighing strengths against methodological and conceptual criticisms
• Distinguishes individual differences explanations from social psychological explanations of the same disorder
• Identifies at least two named social psychological explanations from the specified examples
• Explains the proposed mechanism of each chosen explanation rather than only naming it
• Supports each explanation with relevant evidence, such as cross-cultural or relapse findings
• Evaluates each explanation by weighing strengths against methodological and conceptual criticisms
• Distinguishes social psychological explanations from individual differences explanations of the same disorder
• Identifies antipsychotic medication as a biological method that reduces dopamine activity at D₂ receptors to lessen positive symptoms such as hallucinations.
• Distinguishes typical from atypical antipsychotics by naming the additional serotonin action and the differing side-effect profiles.
• Describes CBT as a psychological method that helps the person evaluate and test the beliefs attached to their symptoms.
• Explains that CBT is typically combined with medication rather than used as a total replacement.
• Compares the two methods by mechanism, target symptoms and strength of supporting evidence.

• 💡Check whether the stem asks for a description, a distinction or an evaluation before selecting an option.
• 💡Reject options that describe a psychological or family-based explanation when the stem asks for a biological one.
• 💡Match each named example to its level of explanation, whether neurotransmitter, brain structure or substance influence, to eliminate mismatched options.
• 💡Read the question stem carefully to check whether it asks you to identify, explain or evaluate before you begin writing
• 💡Anchor each explanation to a named theorist or study where you can, and state the mechanism in one clear sentence
• 💡Reserve time to add a balanced evaluation point for each explanation you present
• 💡Check the question stem to see whether it asks you to identify, explain or evaluate before you begin writing
• 💡State the mechanism of each explanation in one clear sentence, then add supporting evidence
• 💡Include a balanced evaluation point for each explanation, noting the interaction with biological vulnerability
• 💡Learn one clear mechanism for each drug class so you can state it precisely under time pressure.
• 💡Use the term D₂ when describing dopamine receptor blockade and keep the subscript.
• 💡Prepare one comparison sentence linking each method to the symptom type it targets.
• 💡Always cite named researchers and specific statistics where possible (e.g., Gottesman's twin study showing 48% concordance for MZ vs. 17% for DZ twins; Leucht et al.'s meta-analyses).
• 💡Structure evaluation points using PEEL (Point, Evidence, Explain, Link), explicitly linking back to how the evidence affects the clinical validity or real-world utility of the explanation or therapy.
• 💡Address issues of culture and gender bias in diagnostic validity questions, using examples such as elevated diagnosis rates of African-Caribbean individuals in the UK due to cultural misunderstandings of spiritual experiences.

• Describes enlarged ventricles as a cause proven to produce schizophrenia; correct this by presenting it as a correlational structural finding that does not establish causation.
• Treats the dopamine hypothesis as a complete account of all symptoms; correct this by noting that it explains positive symptoms better than negative ones.
• Confuses cannabis influence with a psychological explanation; correct this by framing it as a biological account of how a substance alters brain chemistry.
• Names only one explanation; select and develop at least two from the specified examples
• Describes symptoms of schizophrenia without explaining how they are proposed to cause the disorder; link the feature to the proposed mechanism
• Treats sex differences as proof of a biological cause; consider both biological and social interpretations and evaluate them
• Names only one explanation; select and develop at least two from the specified examples
• Assumes a correlation between family communication and relapse proves that the family caused the disorder; discuss direction of causation and alternative interpretations
• Presents expressed emotion as a fixed trait of relatives; treat it as measured criticism, hostility and over-involvement that can be assessed and addressed
• Claims antipsychotics cure schizophrenia outright; state instead that they manage symptoms and relapse risk rather than providing a cure.
• Treats CBT as simply giving advice or reassurance; describe instead structured collaborative work on the meaning of symptoms.
• Assumes the two methods are mutually exclusive alternatives; explain instead that they are commonly used together.
• Believing schizophrenia equates to 'split personality' or dissociative identity disorder; in psychology, schizophrenia means 'split from reality', not multiple distinct personalities.
• Assuming biological treatments provide a permanent cure; antipsychotic medications manage symptoms by altering neurotransmission but do not eradicate the underlying biological or environmental vulnerabilities.
• Overlooking the difference between proximal and distal causes; cognitive and family dysfunction theories often explain how symptoms manifest (proximal), whereas biological factors generally explain the underlying vulnerability (distal).

1. 1Week 1, Days 1-2: Master clinical characteristics, diagnostic criteria (DSM vs. ICD), and debate issues of inter-rater reliability, co-morbidity, and cultural bias.
2. 2Week 1, Days 3-5: Learn biological explanations (genetics, dopamine, neural correlates) alongside typical and atypical drug therapies, mapping out mechanisms and evaluations.
3. 3Week 2, Days 1-3: Study psychological explanations (Bateson, Expressed Emotion, Frith's cognitive model) and psychological therapies (CBTp, family intervention, token economies).
4. 4Week 2, Days 4-5: Synthesise the topic using the interactionist (diathesis-stress) model and practice timed past exam questions using specific Eduqas mark schemes.

• 📋Short-answer conceptual and application questions (2-4 marks): Defining specific symptoms or identifying explanations from clinical vignettes.
• 📋Methodological and data analysis questions (4-6 marks): Interpreting concordance rate tables, neuroimaging findings, or clinical trial outcome graphs.
• 📋Extended response essay questions (8-15 marks): Requiring balanced description (AO1) and sustained, critical evaluation (AO3) of an explanation, therapy, or diagnostic issue.